Go to deals
Healthcare

Avacta Group has raised funds via a placing and subscription to both institutional and retail investors

Avacta Group Plc has raised US$60.3 million to continue developing next generation cancer therapies.

Avacta’s mission is to shape the future of medicine by developing safe and efficacious drugs and powerful research and diagnostic tools. Avacta is developing novel cancer immunotherapies combining its two proprietary platforms – Affimer® biotherapeutics and pre|CISIONTM tumor-targeted chemotherapy. With this approach, the company aims to address the lack of a durable response to current immunotherapies experienced by most patients.

Oaklins Cavendish’s sister firm finnCap, based in the UK, acted as financial advisor and broker, assisting Avacta’s management team and shareholders all the way from the start to the successful completion of the fundraising. During this process, the team initiated and advised on many aspects, including, among others, securing pre-commitments from both existing and new institutional investors, deal structuring, document preparation and the fundraise pricing and sizing.

Service
Funding, debt advisory & ECM
Parties

Talk to the deal team

 Geoff  Nash

Geoff Nash

Partner

London, United Kingdom
Oaklins Cavendish

Related deals

Intergrin has raised financing provided by Kartesia
Healthcare

Intergrin has raised financing provided by Kartesia

Intergrin has obtained a unitranche loan of approximately US$59 million to refinance existing debt and to further support the growth of different healthcare and well-being initiatives.

Learn more
Simtel Team has raised US$3.5 million through an equity private placement on BSE
Construction & Engineering Services | Energy

Simtel Team has raised US$3.5 million through an equity private placement on BSE

Simtel Team (SMTL), a Romanian engineering and technology company, has raised US$3.5 million through a private placement of shares on the ATS Market of Bucharest Stock Exchange. The offer was closed on the first day, being oversubscribed three times, with the investors placing orders for a total value of US$10.4 million. Following the successful conclusion of the private placement, the anticipated capitalization of the company is approximately US$22 million.

Learn more
Earlypay (ASX:EPY) has raised funds
Financial Services

Earlypay (ASX:EPY) has raised funds

Earlypay (ASX:EPY) has raised US$14.5 million to fund a new trade finance product, while the company puts in place a new warehouse facility.

Learn more